Does ABIRATERONE Cause Prostatic specific antigen increased? 1,581 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,581 reports of Prostatic specific antigen increased have been filed in association with ABIRATERONE (Abiraterone Acetate). This represents 4.6% of all adverse event reports for ABIRATERONE.
1,581
Reports of Prostatic specific antigen increased with ABIRATERONE
4.6%
of all ABIRATERONE reports
96
Deaths
182
Hospitalizations
How Dangerous Is Prostatic specific antigen increased From ABIRATERONE?
Of the 1,581 reports, 96 (6.1%) resulted in death, 182 (11.5%) required hospitalization, and 15 (0.9%) were considered life-threatening.
Is Prostatic specific antigen increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABIRATERONE. However, 1,581 reports have been filed with the FAERS database.
What Other Side Effects Does ABIRATERONE Cause?
Death (5,623)
Fatigue (1,928)
Drug ineffective (1,732)
Therapy cessation (1,602)
Disease progression (1,098)
Hospitalisation (1,034)
Hot flush (989)
Asthenia (891)
Off label use (859)
Fall (804)
What Other Drugs Cause Prostatic specific antigen increased?
ENZALUTAMIDE (3,731)
LEUPROLIDE (2,432)
RADIUM RA-223 DICHLORIDE (449)
RELUGOLIX (335)
BICALUTAMIDE (322)
DOCETAXEL (282)
APALUTAMIDE (251)
DENOSUMAB (220)
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (212)
OLAPARIB (176)
Which ABIRATERONE Alternatives Have Lower Prostatic specific antigen increased Risk?
ABIRATERONE vs ABIRATERONE\ABIRATERONE
ABIRATERONE vs ABOBOTULINUMTOXINA
ABIRATERONE vs ABRAXANE
ABIRATERONE vs ABROCITINIB
ABIRATERONE vs ACALABRUTINIB